AGIO Quote, Trading Chart, Agios Pharmaceuticals Inc.
home / stock / agio / agio quote
$47.44 Last:
-5.67% Change Percent:
$47.63 Open:
$47.44 Previous Close:
$49.85 High:
$46.57 Low:
1,147,817 Volume:
02/26/2021 04:55:16 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-02-26 | 47.63 | 47.44 | 49.85 | 46.57 | 1,147,817 |
| 2021-02-25 | 52.47 | 50.29 | 54.24 | 50.17 | 645,425 |
| 2021-02-24 | 53.8 | 52.89 | 55.25 | 52.53 | 624,425 |
| 2021-02-23 | 53.09 | 54.17 | 55.04 | 51.22 | 839,459 |
| 2021-02-22 | 51.85 | 53.84 | 54.33 | 51.825 | 733,030 |
| 2021-02-19 | 50.7 | 52.18 | 52.79 | 50.45 | 515,560 |
| 2021-02-18 | 51.38 | 50.34 | 51.955 | 49.89 | 594,969 |
| 2021-02-17 | 54.37 | 52.5 | 54.37 | 51.61 | 718,621 |
| 2021-02-16 | 55.38 | 54.37 | 55.89 | 53.82 | 724,755 |
| 2021-02-15 | 57.63 | 55.89 | 58.25 | 55.69 | 631,298 |
| 2021-02-12 | 57.63 | 55.89 | 58.25 | 55.69 | 631,184 |
| 2021-02-11 | 57.32 | 57.5 | 58.93 | 55.43 | 658,551 |
| 2021-02-10 | 55.14 | 56.68 | 58.19 | 53.83 | 1,454,585 |
| 2021-02-09 | 55.2 | 55.01 | 57.22 | 54.2199 | 712,422 |
| 2021-02-08 | 52.94 | 55.82 | 56.08 | 52.64 | 837,639 |
| 2021-02-05 | 50.94 | 52.84 | 53.39 | 50.36 | 450,372 |
| 2021-02-04 | 51.525 | 50.49 | 51.525 | 50.04 | 391,880 |
| 2021-02-03 | 50.5 | 51.25 | 52.48 | 50.5 | 433,014 |
| 2021-02-02 | 49.05 | 50.7 | 50.98 | 49 | 677,104 |
| 2021-02-01 | 47.5 | 48.79 | 49.12 | 47.25 | 460,364 |
Agios Pharmaceuticals Inc. Company Name:
AGIO Stock Symbol:
NASDAQ Market:
Agios Pharmaceuticals Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
-
– In Partnership with the Sickle Cell Community Consortium, Agios Works to Address Educational Resource Gaps Caused by COVID-19 for Students with Sickle Cell Disease – – Company to Host Facebook Live Discussion with Pyruvate Kinase (PK) Deficiency Patient, C...
-
Image source: The Motley Fool. Agios Pharmaceuticals Inc (NASDAQ: AGIO) Q4 2020 Earnings Call Feb 25, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: Agios Pharmaceuticals Inc (AGIO) Q4 2020 Earnings Call Transcript...
-
– Strong Commercial Execution for Second Full Year of TIBSOVO ® with Fourth Quarter Net Revenue of $39.1M and $121.1M for Full Year 2020 – – Sale of Oncology Portfolio Expected to Close Around March 31 Subject to March 25...